November 2014

Study supports CVD timing hypothesis in menopause

Early results of the ELITE study find women who started hormone therapy early after menopause saw a significant slowing of atherosclerotic progression, whereas those who waited more than a decade saw no impact on vascular health, supporting the “timing hypothesis”.

New drug data finds sex/race inclusion lacking

In response to the call for more sex inclusion data in drug studies, the FDA has developed  Drug Trials Snapshot a pilot project to provide information about the sex, age, race and ethnicity of clinical trial participants for a small group of recently approved drugs. In addition to information about who participates in the trial, each Snapshot also includes information on how the study was designed, results of the efficacy and safety studies and, if known, differences in efficacy and side effects among sex, race and age (referred to as subgroups).

Tactics to slow cognitive decline due to Alzheimer’s

The cognitive decline associated with Alzheimer’s Disease (AD) may be related to the particular pathology of this disease which researchers continue to study.  One study at Stanford suggests that if you slow the pathology (biologic)  progression it could slow the path to full dementia.   In other words, if you stay healthier, you may slow the biological process that causes the progression of dementia.  Some suggested tactics:

Menopause hormone therapy: what do we know today?

Today, Many women live beyond age 80 and as a result may be postmenopausal for over 30 years. Each woman has a unique range of symptoms.  Hormone therapy has been widely prescribed since the early 60s despite limited research to relieve unpleasant menopausal symptoms.  However,  alarms were raised in the 1990′s that have led to a whole battery of new research on hormone therapy that continues to this day.

Skin care tips for middle agers

Keeping skin healthy is important, especially as people get older, according to Bethanee J. Schlosser, MD, PhD, FAAD, assistant professor of dermatology and director of Women’s Skin Health at Northwestern University, Feinberg School of Medicine in Chicago. Dr. Schlosser is also on the Leadership Council of the Women’s Health Research Institute.  Read some helpful tips  HERE.

Source: Digital Journal November 12, 2014

Research Finds Minor Cosmetic Surgery Safe

Minimally invasive cosmetic procedures, including fillers, neurotoxins and laser and energy device procedures are exceedingly safe and have essentially no risk of serious adverse events, reports a new Northwestern Medicine® study that analyzed more than 20,000 procedures around the country.

This is believed to be the first large, multi-center study that prospectively analyzed the rate of adverse events among tens of thousands of cosmetic procedures done at many centers around the United States by experienced dermatologists. These procedures are used to decrease the visible facial signs of aging.